637343-86-3 Usage
Uses
Used in Pharmaceutical Industry:
(R)-5-(HYDROXYMETHYL)-3-METHYLOXAZOLIDIN-2-ONE is used as an antibiotic for the treatment of various bacterial infections. Its application is primarily due to its effectiveness in inhibiting bacterial protein synthesis, which results in the suppression of bacterial growth and reproduction.
Used in Respiratory Tract Infections:
In the medical field, (R)-5-(HYDROXYMETHYL)-3-METHYLOXAZOLIDIN-2-ONE is used as a therapeutic agent for respiratory tract infections. Its application in this area is attributed to its ability to target and combat the bacteria responsible for causing these infections.
Used in Skin and Soft Tissue Infections:
(R)-5-(HYDROXYMETHYL)-3-METHYLOXAZOLIDIN-2-ONE is also utilized as a treatment for skin and soft tissue infections. Its application in this context is due to its broad-spectrum activity against various bacterial pathogens that may cause such infections.
Precautionary Note:
It is important to exercise caution when using (R)-5-(HYDROXYMETHYL)-3-METHYLOXAZOLIDIN-2-ONE, especially in individuals with a history of liver or kidney problems. This is because the compound may potentially cause adverse effects in these populations.
Check Digit Verification of cas no
The CAS Registry Mumber 637343-86-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,7,3,4 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 637343-86:
(8*6)+(7*3)+(6*7)+(5*3)+(4*4)+(3*3)+(2*8)+(1*6)=173
173 % 10 = 3
So 637343-86-3 is a valid CAS Registry Number.
637343-86-3Relevant academic research and scientific papers
1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES
-
Page/Page column 302, (2016/07/05)
The present invention relates to 1,3-thiazol-2-yl substituted benzamide compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neurogenic disorder, as a sole agent or in combination with other active ingredients.
Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives
Wang, Guijun,Ella-Menye, Jean-Rene,Sharma, Vibha
, p. 2177 - 2181 (2007/10/03)
We report here the design, synthesis, and antibacterial activities of novel classes of compounds containing chiral 1,3-oxazinan-2-ones and oxazolidinones as the basic core structures. These compounds are tertiary amines containing the core structures and
